Nick Leschly '94 (CEO, bluebird bio)

Nick Leschly '94 (CEO, bluebird bio)

Chief Scientific Officer Seminar Series

Event Date/Location

October 12, 2017 - 4:00 pm
Thomas Laboratory 003


  • photo of Nick Leschly

    Nick Leschly, '94

    Chief bluebird
    bluebird bio, Inc.

    Nick Leschly has served as chief bluebird since September 2010. Formerly, Nick was a partner and founding member of Third Rock Ventures in 2007. Nick played an integral role in the overall formation, development and business strategy of several of Third Rock’s portfolio companies, including Agios Pharmaceuticals, Inc. and Edimer Pharmaceuticals, Inc. Prior to joining Third Rock, he worked at Millennium Pharmaceuticals, leading several early-stage drug development programs and served as the product leader for VELCADE. Nick also founded and served as chief executive officer of MedXtend Corporation. He received his B.S. in molecular biology from Princeton University and his MBA from Wharton Business School. He currently serves as a board member of the Biotechnology Innovation Organization (BIO), Synlogic and Proclara Biosciences.


Gene Therapy Revolution for Patients – bluebird Style!


Free and open to the university community and the public.


Bonnie Bassler, Department of Molecular Biology